Skip to main content

Table 3 Changes in the percentage of patients presenting symptoms of malaria attack during the study

From: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria

Symptoms

Percentage of patients with symptoms on D0

Percentage of patients with symptoms on D3

Percentage of patients with symptoms on D14

One intake N = 161

Two intakes N = 155

One intake N = 161

Two intakes N = 155

One intake N = 161

Two intakes N = 155

Headache

88.8%

91.0%

5.0%

1.9%

0.6%

0.7%

Perspiration

59.0%

55.5%

10.6%

9.7%

1.2%

3.9%

Dizziness

42.2%

45.2%

8.7%

7.1%

0.6%

1.3%

Chills

69.6%

67.7%

3.1%

4.5%

0.6%

2.6%

Pain

41.6%

40.6%

5.7%

10.3%

1.9%

2.6%

Anorexia

70.8%

71.6%

19.8%

15.5%

1.2%

0

Asthenia

77.0%

74.8%

39.1%

38.7%

0.6%

0.6%

Jaundice

1.9%

0.6%

0.6%

0

0

0

Skinfold

0.6%

0.6%

1.3%

1.3%

0

0

Hepatomegaly

7.5%

5.8%

7.5%

3.9%

5.8%

3.9%

Vomiting in 24 hours

47.8%

43.9%

3.7%

2.5%

0

0

Diarrhoea in 24 hours

9.3%

8.4%

1.8%

2.5%

0

1.3%